Duncan Borthwick

Duncan Borthwick completed his PhD on Cystic Fibrosis gene therapy at the MRC Human Genetics Unit in Edinburgh and the University of North Carolina, Chapel Hill. Since leaving the bench, he has held a range of commercial leadership roles, helping to bring novel life science technologies to wider markets. He currently serves as Sales Director at Green Elephant Biotech, a company focused on enabling scalable adherent cell processes.